desoxycorticosterone has been researched along with atrasentan in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, LY; Schiffrin, EL; Turgeon, A | 1 |
| Schiffrin, EL; Sharifi, AM | 1 |
| Clarke, N; Fuchs, LC; Giulumian, AD; Pollock, DM | 1 |
| Li, JS; Schiffrin, EL; Turgeon, A | 1 |
| Allcock, GH; Pollock, DM; Venema, RC | 1 |
| Hashimoto, N; Kitano, R; Kuro, T; Matsumura, Y; Ohkita, M; Opgenorth, TJ; Taira, S; Takaoka, M | 1 |
| Larouche, I; Schiffrin, EL | 1 |
| Fink, GD; Galligan, JJ; Johnson, RJ | 1 |
| Bianciotti, LG; De Bold, AJ | 1 |
| Ammarguellat, F; Larouche, I; Schiffrin, EL | 1 |
| Derebail, VK; Pollock, DM; Pollock, JS; Yamamoto, T | 1 |
| Berthelot, A; Berthon, N; Fellmann, D; Laurant, P | 1 |
| Banes, AK; Chen, AF; Fink, GD; Galligan, JJ; Li, L; Watts, SW | 1 |
| Chen, AF; Fink, GD; Hesslinger, C; Kapatos, G; Kovesdi, I; Lookingland, KJ; Yang, XQ; Zheng, JS | 1 |
| Allan, A; Brown, L; Fenning, A; Hoey, A; Levick, S | 1 |
| Hasegawa, Y; Kawanishi, H; Matsumura, Y; Nakano, D; Ohkita, M; Ohno, Y; Takaoka, M | 1 |
| Carneiro, FS; Carneiro, ZN; Ergul, A; Giachini, FR; Leite, R; Lima, VV; Nunes, KP; Tostes, RC; Webb, RC | 1 |
| Carneiro, FS; Carneiro, ZN; Clinton Webb, R; Ergul, A; Giachini, FR; Leite, R; Lima, VV; Nogueira, EF; Nunes, KP; Rainey, WE; Tostes, RC | 1 |
| Carneiro, FS; Carneiro, ZN; Carvalho, MH; Ergul, A; Fortes, ZB; Giachini, FR; Lima, VV; Pollock, DM; Saleh, MA; Tostes, RC; Webb, RC | 1 |
| Kimura, K; Koyama, M; Matsumura, Y; Ohkita, M | 1 |
20 other study(ies) available for desoxycorticosterone and atrasentan
| Article | Year |
|---|---|
Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Topics: Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Hemodynamics; Hypertension; Hypertension, Renovascular; Male; Phenylpropionates; Pyrimidines; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Renin | 1997 |
Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
Topics: Animals; Aorta; Apoptosis; Atrasentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Hypertension; Male; Phenylpropionates; Pyrimidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sodium Chloride | 1997 |
Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Topics: Animals; Atrasentan; Blood Pressure; Coronary Vessels; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Male; Mesenteric Arteries; Potassium Chloride; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium Chloride; Vasoconstriction | 1998 |
Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Topics: Animals; Arteries; Atrasentan; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Hypertension; Phenylpropionates; Pyrimidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium Chloride; Time Factors | 1998 |
ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Topics: Animals; Atrasentan; Blood Pressure; Creatinine; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Glomerular Filtration Rate; Hypertension; Kidney; Kidney Cortex; Kidney Medulla; Male; Nephrectomy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger; Sodium, Dietary; Stereoisomerism; Time Factors; Transcription, Genetic; Water-Electrolyte Balance | 1998 |
Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Topics: Animals; Aorta; Atrasentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-2; Hypertension; Male; Nephrectomy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin | 1999 |
Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
Topics: Animals; Atrasentan; Coronary Circulation; Coronary Vessels; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Heart; Hypertension, Renovascular; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; Sodium Chloride, Dietary | 1999 |
Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension.
Topics: Animals; Atrasentan; Blood Volume; Consciousness; Desoxycorticosterone; Endothelin Receptor Antagonists; Ganglionic Blockers; Hexamethonium; Hypertension; Jugular Veins; Male; Muscle Tonus; Muscle, Smooth, Vascular; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; Sodium Chloride, Dietary; Sympathetic Nervous System | 2000 |
Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension.
Topics: Animals; Atrasentan; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Desoxycorticosterone; Endothelin Receptor Antagonists; Gene Expression Regulation; Heart; Heart Ventricles; Hypertension; Male; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium, Dietary; Transcription, Genetic | 2000 |
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Topics: Animals; Atrasentan; Blood Pressure; Collagen; Collagen Type I; Desoxycorticosterone; Endothelin A Receptor Antagonists; Fibrosis; Hypertension; Male; Myocardium; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrasentan; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Desoxycorticosterone; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Male; Natriuresis; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2000 |
Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats.
Topics: Animals; Aorta; Atrasentan; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Heart Rate; Heart Ventricles; Hypertension; Kidney; Magnesium Oxide; Male; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2003 |
NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
Topics: Acetophenones; Allopurinol; Animals; Atrasentan; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Venae Cavae; Viper Venoms; Xanthine Oxidase | 2003 |
Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
Topics: Acetophenones; Animals; Antioxidants; Atrasentan; Biopterins; Carotid Arteries; Cyclic N-Oxides; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Gene Transfer Techniques; Genetic Therapy; GTP Cyclohydrolase; Humans; Hypertension; In Vitro Techniques; Male; Nitric Oxide; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium Chloride; Spin Labels; Superoxides; Vasodilation | 2003 |
Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
Topics: Acetylcholine; Action Potentials; Animals; Aorta, Thoracic; Atrasentan; Body Weight; Collagen; Desoxycorticosterone; Disease Models, Animal; Drinking; Endothelin A Receptor Antagonists; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardial Contraction; Nephrectomy; Norepinephrine; Papillary Muscles; Potassium Chloride; Pyrrolidines; Rats; Rats, Wistar; Ventricular Remodeling | 2005 |
Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Topics: Animals; Aorta, Thoracic; Atrasentan; Blood Pressure; Desoxycorticosterone; Dopamine beta-Hydroxylase; Endothelin A Receptor Antagonists; Endothelin-1; Female; Hypertension; Injections, Subcutaneous; Male; Mice; Mice, Knockout; Mice, Transgenic; Organ Size; Ovariectomy; Pyrrolidines; Rats; Receptor, Endothelin B; Sex Factors; Superoxides; Uterus; Weight Gain | 2007 |
DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum.
Topics: Animals; Atrasentan; Desoxycorticosterone; Endothelin A Receptor Antagonists; Endothelin-1; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth; Penile Erection; Penis; Pyrrolidines; RNA, Messenger; Sodium Chloride; Vasodilation | 2008 |
Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Topics: Animals; Atrasentan; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin B Receptor Antagonists; Endothelin-1; Erectile Dysfunction; Gene Expression; Hypertension; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Penis; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger | 2008 |
O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.
Topics: Acetylglucosamine; Animals; Aorta, Thoracic; Atrasentan; Blood Pressure; Blotting, Western; Desoxycorticosterone; Drug Synergism; Endothelin-1; Glycoproteins; Glycosylation; Hypertension; In Vitro Techniques; Male; N-Acetylglucosaminyltransferases; Phenylephrine; Pyrrolidines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats.
Topics: Animals; Atrasentan; Desoxycorticosterone; Disease Models, Animal; Disease Susceptibility; Endothelin-1; Hypertension; Kidney Diseases; Male; NF-kappa B; Nitric Oxide; Nitroarginine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Severity of Illness Index; Sodium Chloride, Dietary; Thiocarbamates | 2012 |